Literature DB >> 29951923

Broadening the scope of epidemiologic dementia research.

Sirwan K L Darweesh1,2,3, Frank J Wolters4,5,6, M Arfan Ikram5, Daniel Bos4,5,7, Albert Hofman4,5.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29951923     DOI： 10.1007/s10654-018-0421-9

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


× No keyword cloud information.
  25 in total

1.  Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study.

Authors:  Lon White; Brent J Small; Helen Petrovitch; G Webster Ross; Kamal Masaki; Robert D Abbott; John Hardman; Daron Davis; James Nelson; William Markesbery
Journal:  J Geriatr Psychiatry Neurol       Date:  2005-12       Impact factor: 2.680

2.  Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Authors:  Susanne G Mueller; Michael W Weiner; Leon J Thal; Ronald C Petersen; Clifford R Jack; William Jagust; John Q Trojanowski; Arthur W Toga; Laurel Beckett
Journal:  Alzheimers Dement       Date:  2005-07       Impact factor: 21.566

3.  Incident dementia in women is preceded by weight loss by at least a decade.

Authors:  D S Knopman; S D Edland; R H Cha; R C Petersen; W A Rocca
Journal:  Neurology       Date:  2007-08-21       Impact factor: 9.910

4.  The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease.

Authors:  Kathryn A Ellis; Ashley I Bush; David Darby; Daniela De Fazio; Jonathan Foster; Peter Hudson; Nicola T Lautenschlager; Nat Lenzo; Ralph N Martins; Paul Maruff; Colin Masters; Andrew Milner; Kerryn Pike; Christopher Rowe; Greg Savage; Cassandra Szoeke; Kevin Taddei; Victor Villemagne; Michael Woodward; David Ames
Journal:  Int Psychogeriatr       Date:  2009-05-27       Impact factor: 3.878

5.  Inflammatory markers and the risk of dementia and Alzheimer's disease: A meta-analysis.

Authors:  Sirwan K L Darweesh; Frank J Wolters; M Arfan Ikram; Frank de Wolf; Daniel Bos; Albert Hofman
Journal:  Alzheimers Dement       Date:  2018-03-29       Impact factor: 21.566

6.  The neuropathology of older persons with and without dementia from community versus clinic cohorts.

Authors:  Julie A Schneider; Neelum T Aggarwal; Lisa Barnes; Patricia Boyle; David A Bennett
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 7.  Dementia prevention, intervention, and care.

Authors:  Gill Livingston; Andrew Sommerlad; Vasiliki Orgeta; Sergi G Costafreda; Jonathan Huntley; David Ames; Clive Ballard; Sube Banerjee; Alistair Burns; Jiska Cohen-Mansfield; Claudia Cooper; Nick Fox; Laura N Gitlin; Robert Howard; Helen C Kales; Eric B Larson; Karen Ritchie; Kenneth Rockwood; Elizabeth L Sampson; Quincy Samus; Lon S Schneider; Geir Selbæk; Linda Teri; Naaheed Mukadam
Journal:  Lancet       Date:  2017-07-20       Impact factor: 202.731

8.  The potential for prevention of dementia across two decades: the prospective, population-based Rotterdam Study.

Authors:  Renée F A G de Bruijn; Michiel J Bos; Marileen L P Portegies; Albert Hofman; Oscar H Franco; Peter J Koudstaal; M Arfan Ikram
Journal:  BMC Med       Date:  2015-07-21       Impact factor: 8.775

Review 9.  Cardiovascular risk factors and future risk of Alzheimer's disease.

Authors:  Renée F A G de Bruijn; M Arfan Ikram
Journal:  BMC Med       Date:  2014-11-11       Impact factor: 8.775

10.  Potential for primary prevention of Alzheimer's disease: an analysis of population-based data.

Authors:  Sam Norton; Fiona E Matthews; Deborah E Barnes; Kristine Yaffe; Carol Brayne
Journal:  Lancet Neurol       Date:  2014-08       Impact factor: 44.182
View more
  1 in total

1.  Objectives, design and main findings until 2020 from the Rotterdam Study.

Authors:  M Arfan Ikram; Guy Brusselle; Mohsen Ghanbari; André Goedegebure; M Kamran Ikram; Maryam Kavousi; Brenda C T Kieboom; Caroline C W Klaver; Robert J de Knegt; Annemarie I Luik; Tamar E C Nijsten; Robin P Peeters; Frank J A van Rooij; Bruno H Stricker; André G Uitterlinden; Meike W Vernooij; Trudy Voortman
Journal:  Eur J Epidemiol       Date:  2020-05-04       Impact factor: 8.082
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.